-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Finance App News, Harbin Pharmaceutical Co., Ltd. (600664.SH) issued an announcement. Recently, Harbin Pharmaceutical Group Bioengineering Co., Ltd., a subsidiary of the company, received the “Notice of Approval of the Application for the Marketing of Chemical Ingredients” on sodium sulfate issued by the State Drug Administration.

Zhitongcaijing·10/12/2026 07:57:09
Listen to the news
Zhitong Finance App News, Harbin Pharmaceutical Co., Ltd. (600664.SH) issued an announcement. Recently, Harbin Pharmaceutical Group Bioengineering Co., Ltd., a subsidiary of the company, received the “Notice of Approval of the Application for the Marketing of Chemical Ingredients” on sodium sulfate issued by the State Drug Administration.